SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $207,000 | -36.9% | 1,293 | -53.1% | 0.01% | -27.3% |
| Q1 2019 | $328,000 | +27.1% | 2,754 | +16.2% | 0.01% | +10.0% |
| Q4 2018 | $258,000 | -32.5% | 2,370 | 0.0% | 0.01% | -23.1% |
| Q3 2018 | $382,000 | +40.4% | 2,370 | +14.8% | 0.01% | +30.0% |
| Q2 2018 | $272,000 | -48.1% | 2,064 | -70.8% | 0.01% | -50.0% |
| Q1 2018 | $524,000 | +4.2% | 7,064 | -21.9% | 0.02% | 0.0% |
| Q4 2017 | $503,000 | +22.7% | 9,041 | 0.0% | 0.02% | +11.1% |
| Q3 2017 | $410,000 | +34.9% | 9,041 | +0.2% | 0.02% | +28.6% |
| Q2 2017 | $304,000 | +6.7% | 9,026 | -6.2% | 0.01% | -6.7% |
| Q1 2017 | $285,000 | +14.9% | 9,626 | +6.6% | 0.02% | +15.4% |
| Q4 2016 | $248,000 | -55.2% | 9,026 | +0.3% | 0.01% | -55.2% |
| Q3 2016 | $553,000 | +125.7% | 9,000 | -29.7% | 0.03% | +107.1% |
| Q2 2016 | $245,000 | +4.7% | 12,800 | +6.7% | 0.01% | +7.7% |
| Q1 2016 | $234,000 | -49.9% | 12,000 | -0.8% | 0.01% | -45.8% |
| Q4 2015 | $467,000 | +21.3% | 12,100 | +0.8% | 0.02% | +14.3% |
| Q3 2015 | $385,000 | -2.8% | 12,000 | -7.7% | 0.02% | +16.7% |
| Q2 2015 | $396,000 | +52.3% | 13,000 | -33.7% | 0.02% | +5.9% |
| Q1 2015 | $260,000 | -8.5% | 19,600 | 0.0% | 0.02% | -19.0% |
| Q4 2014 | $284,000 | -1.0% | 19,600 | +44.1% | 0.02% | -8.7% |
| Q3 2014 | $287,000 | -29.5% | 13,600 | -0.5% | 0.02% | -23.3% |
| Q2 2014 | $407,000 | +23.3% | 13,674 | -0.2% | 0.03% | +20.0% |
| Q1 2014 | $330,000 | +18.7% | 13,708 | +0.4% | 0.02% | +13.6% |
| Q4 2013 | $278,000 | -35.0% | 13,654 | +50.8% | 0.02% | -12.0% |
| Q3 2013 | $428,000 | -13.9% | 9,054 | -30.6% | 0.02% | -37.5% |
| Q2 2013 | $497,000 | – | 13,054 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |